CADL – candel therapeutics, inc. (US:NASDAQ)

News

Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 [Yahoo! Finance]
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Candel Therapeutics (NASDAQ:CADL) was downgraded by analysts at Wall Str
Candel Therapeutics (NASDAQ:CADL) had its price target lowered by analysts at Citigroup Inc. from $25.00 to $24.00. They now have a "buy" rating on the stock.
Candel Therapeutics GAAP EPS of -$0.21 misses by $0.03 [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com